1 domain / 2 areas / 1 specialization
BlackRock
Data updated
BlackRock is a global asset manager and fiduciary investor founded in 1988 in New York. Its investment stewardship business engages with public companies and votes on behalf of clients across index and active portfolios. Public BlackRock location pages list its New York office at 50 Hudson Yards, New York, NY 10001, United States.
In the psychedelic ecosystem, BlackRock is relevant primarily as a large public-markets stakeholder rather than a dedicated psychedelic specialist. Its stewardship and portfolio activities span global public companies and multiple asset classes, so it may appear as a shareholder in listed life sciences or healthcare names even though it does not advertise a public psychedelic focus.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.
BlackRock is best understood as a large-scale global asset manager with a stewardship-led approach to public markets, not as a thematic psychedelic investor. Its public materials emphasize fiduciary duty, long-term value creation, and engagement with companies across global markets, which makes it a consequential shareholder in the broader healthcare and life sciences landscape. I did not find public evidence of a dedicated psychedelic investment strategy or a clearly disclosed psychedelic portfolio focus.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
No Public Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- Founded
- 1988
- HQ
- New York, NY 10001, United States
- Website
- Visit